← All stocks

Senti Biosciences Holdings, Inc.

SNTI Net selling
CIK 0001854270 #5167 in the set updated 21 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$24.41K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$24.41K
4 of 4 sales
Net
−$24.41K
−$24.41K against sales at will

By person

9 insiders · 5 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Lu Timothy K
CEO
$18.34K (2)
−$18.34K
639,583
$2.79M
Rajangam Kanya
Pres. & Chief Med. & Dev. Off.
$6.07K (2)
−$6.07K
107,843
$471.27K
Celadon Partners SPV 24 entity
10% owner
9,777,000
$42.73M
New Enterprise Associates 15, L.P. entity
10% owner
3,775,615
$16.50M
+753.0%
BAYER HEALTHCARE LLC entity
10% owner
2,809,848
$12.28M
+378.0%
Farokhzad Omid
Director
250,000
$1.09M
KNOBELMAN DEBORAH
Chief Financial Officer
131,000
$572.47K
Epstein David R
Director
123,252
$538.61K
+1,048%
Dynamics Sponsor LLC entity
Director
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 6.8 over the window, from 4,588,645 to 31,144,754 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Rajangam Kanya
10 Mar 2025
Pres. & Chief Med. & Dev. Off.
Exercised, kept indirect
33,000
$2.25
$74.25K
Rajangam Kanya
6 Feb 2025
Pres. & Chief Med. & Dev. Off.
Sell
182
$4.37
$795.34
Lu Timothy K
6 Feb 2025
CEO
Sell
545
$4.36
$2.38K
Rajangam Kanya
4 Feb 2025
Pres. & Chief Med. & Dev. Off.
Sell
1,297
$4.07
$5.28K
Lu Timothy K
4 Feb 2025
CEO
Sell
3,922
$4.07
$15.96K

What was left out

Form 4 filings counted 57
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 39,566,835
History held since 10 Jun 2022